KFS
Kaizen Financial Strategies’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Buy |
4,362
+162
| +4% | +$30.1K | 0.41% | 44 |
|
|
2025
Q1 | $880K | Buy |
4,200
+200
| +5% | +$41.9K | 0.51% | 33 |
|
|
2024
Q4 | $711K | Buy |
4,000
+6
| +0.2% | +$1.07K | 0.4% | 42 |
|
|
2024
Q3 | $789K | Buy |
3,994
+17
| +0.4% | +$3.36K | 0.46% | 39 |
|
|
2024
Q2 | $743K | Buy |
3,977
+621
| +19% | +$116K | 0.46% | 37 |
|
|
2024
Q1 | $611K | Buy |
3,356
+359
| +12% | +$65.4K | 0.41% | 44 |
|
|
2023
Q4 | $464K | Buy |
2,997
+373
| +14% | +$57.8K | 0.35% | 52 |
|
|
2023
Q3 | $391K | Sell |
2,624
-229
| -8% | -$34.1K | 0.33% | 51 |
|
|
2023
Q2 | $385K | Sell |
2,853
-23
| -0.8% | -$3.1K | 0.33% | 57 |
|
|
2023
Q1 | $458K | Buy |
2,876
+3
| +0.1% | +$478 | 0.45% | 42 |
|
|
2022
Q4 | $441K | Buy |
2,873
+2
| +0.1% | +$307 | 0.44% | 51 |
|
|
2022
Q3 | $385K | Sell |
2,871
-94
| -3% | -$12.6K | 0.39% | 63 |
|
|
2022
Q2 | $454K | Buy |
2,965
+19
| +0.6% | +$2.91K | 0.45% | 59 |
|
|
2022
Q1 | $478K | Sell |
2,946
-176
| -6% | -$28.6K | 0.37% | 65 |
|
|
2021
Q4 | $423K | Sell |
3,122
-399
| -11% | -$54.1K | 0.32% | 84 |
|
|
2021
Q3 | $380K | Buy |
+3,521
| New | +$380K | 0.31% | 83 |
|
|
2021
Q1 | $391K | Sell |
3,610
-3,249
| -47% | -$352K | 0.37% | 79 |
|
|
2020
Q4 | $735K | Buy |
+6,859
| New | +$735K | 0.82% | 34 |
|